allicin has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, L; Cao, Y; Fu, B; Gao, J; Guan, X; Huang, W; Qi, H; Ren, J; Shi, P; Song, C; Sun, H | 1 |
| Brill, A; Dashevsky, O; Hershkoviz, R; Kalchenko, V; Sela, U | 1 |
2 other study(ies) available for allicin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Allicin improves the function of cardiac microvascular endothelial cells by increasing PECAM-1 in rats with cardiac hypertrophy.
Topics: Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Disulfides; Endothelial Cells; Endothelium, Vascular; Gene Silencing; Male; Myocardium; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sulfinic Acids | 2018 |
Allicin inhibits blood vessel growth and downregulates Akt phosphorylation and actin polymerization.
Topics: Actins; Animals; Aorta; Cattle; Cell Movement; Cells, Cultured; Cytoskeleton; Disulfides; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Male; Microtubules; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Sulfinic Acids; Tubulin | 2008 |